Adaption of an Episomal Antisense Silencing Approach for Investigation of the Phenotype Switch of Staphylococcus aureus Small-Colony Variants

Staphylococcus aureus small-colony variants (SCVs) are associated with chronic, persistent, and relapsing courses of infection and are characterized by slow growth combined with other phenotypic and molecular traits. Although certain mechanisms have been described, the genetic basis of clinical SCVs...

Full description

Bibliographic Details
Main Authors: Nina Schleimer, Ursula Kaspar, Britta Ballhausen, Sarah A. Fotiadis, Jessica M. Streu, André Kriegeskorte, Richard A. Proctor, Karsten Becker
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.02044/full
_version_ 1818974114435563520
author Nina Schleimer
Ursula Kaspar
Britta Ballhausen
Sarah A. Fotiadis
Jessica M. Streu
André Kriegeskorte
Richard A. Proctor
Karsten Becker
author_facet Nina Schleimer
Ursula Kaspar
Britta Ballhausen
Sarah A. Fotiadis
Jessica M. Streu
André Kriegeskorte
Richard A. Proctor
Karsten Becker
author_sort Nina Schleimer
collection DOAJ
description Staphylococcus aureus small-colony variants (SCVs) are associated with chronic, persistent, and relapsing courses of infection and are characterized by slow growth combined with other phenotypic and molecular traits. Although certain mechanisms have been described, the genetic basis of clinical SCVs remains often unknown. Hence, we adapted an episomal tool for rapid identification and investigation of putative SCV phenotype-associated genes via antisense gene silencing based on previously described Tnl0-encoded tet-regulatory elements. Targeting the SCV phenotype-inducing enoyl-acyl-carrier-protein reductase gene (fabI), plasmid pSN1-AS‘fabI’ was generated leading to antisense silencing, which was proven by pronounced growth retardation in liquid cultures, phenotype switch on solid medium, and 200-fold increase of antisense ‘fabI’ expression. A crucial role of TetR repression in effective regulation of the system was demonstrated. Based on the use of anhydrotetracycline as effector, an easy-to-handle one-plasmid setup was set that may be applicable to different S. aureus backgrounds and cell culture studies. However, selection of the appropriate antisense fragment of the target gene remains a critical factor for effectiveness of silencing. This inducible gene expression system may help to identify SCV phenotype-inducing genes, which is prerequisite for the development of new antistaphylococcal agents and future alternative strategies to improve treatment of therapy-refractory SCV-related infections by iatrogenically induced phenotypic switch. Moreover, it can be used as controllable phenotype switcher to examine important aspects of SCV biology in cell culture as well as in vivo.
first_indexed 2024-12-20T15:34:55Z
format Article
id doaj.art-9a74fe5bf8434a21ae94504943ab00bb
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-20T15:34:55Z
publishDate 2019-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-9a74fe5bf8434a21ae94504943ab00bb2022-12-21T19:35:27ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-09-011010.3389/fmicb.2019.02044477176Adaption of an Episomal Antisense Silencing Approach for Investigation of the Phenotype Switch of Staphylococcus aureus Small-Colony VariantsNina Schleimer0Ursula Kaspar1Britta Ballhausen2Sarah A. Fotiadis3Jessica M. Streu4André Kriegeskorte5Richard A. Proctor6Karsten Becker7Institute of Medical Microbiology, University Hospital Münster, Münster, GermanyInstitute of Medical Microbiology, University Hospital Münster, Münster, GermanyInstitute of Medical Microbiology, University Hospital Münster, Münster, GermanyInstitute of Medical Microbiology, University Hospital Münster, Münster, GermanyInstitute of Medical Microbiology, University Hospital Münster, Münster, GermanyInstitute of Medical Microbiology, University Hospital Münster, Münster, GermanyDepartments of Medical Microbiology/Immunology and Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, United StatesInstitute of Medical Microbiology, University Hospital Münster, Münster, GermanyStaphylococcus aureus small-colony variants (SCVs) are associated with chronic, persistent, and relapsing courses of infection and are characterized by slow growth combined with other phenotypic and molecular traits. Although certain mechanisms have been described, the genetic basis of clinical SCVs remains often unknown. Hence, we adapted an episomal tool for rapid identification and investigation of putative SCV phenotype-associated genes via antisense gene silencing based on previously described Tnl0-encoded tet-regulatory elements. Targeting the SCV phenotype-inducing enoyl-acyl-carrier-protein reductase gene (fabI), plasmid pSN1-AS‘fabI’ was generated leading to antisense silencing, which was proven by pronounced growth retardation in liquid cultures, phenotype switch on solid medium, and 200-fold increase of antisense ‘fabI’ expression. A crucial role of TetR repression in effective regulation of the system was demonstrated. Based on the use of anhydrotetracycline as effector, an easy-to-handle one-plasmid setup was set that may be applicable to different S. aureus backgrounds and cell culture studies. However, selection of the appropriate antisense fragment of the target gene remains a critical factor for effectiveness of silencing. This inducible gene expression system may help to identify SCV phenotype-inducing genes, which is prerequisite for the development of new antistaphylococcal agents and future alternative strategies to improve treatment of therapy-refractory SCV-related infections by iatrogenically induced phenotypic switch. Moreover, it can be used as controllable phenotype switcher to examine important aspects of SCV biology in cell culture as well as in vivo.https://www.frontiersin.org/article/10.3389/fmicb.2019.02044/fullStaphylococcus aureussmall-colony variant (SCV)antisense silencingphenotype switchenoyl-acyl-carrier-protein reductase gene (fabI)tet-regulatory expression system
spellingShingle Nina Schleimer
Ursula Kaspar
Britta Ballhausen
Sarah A. Fotiadis
Jessica M. Streu
André Kriegeskorte
Richard A. Proctor
Karsten Becker
Adaption of an Episomal Antisense Silencing Approach for Investigation of the Phenotype Switch of Staphylococcus aureus Small-Colony Variants
Frontiers in Microbiology
Staphylococcus aureus
small-colony variant (SCV)
antisense silencing
phenotype switch
enoyl-acyl-carrier-protein reductase gene (fabI)
tet-regulatory expression system
title Adaption of an Episomal Antisense Silencing Approach for Investigation of the Phenotype Switch of Staphylococcus aureus Small-Colony Variants
title_full Adaption of an Episomal Antisense Silencing Approach for Investigation of the Phenotype Switch of Staphylococcus aureus Small-Colony Variants
title_fullStr Adaption of an Episomal Antisense Silencing Approach for Investigation of the Phenotype Switch of Staphylococcus aureus Small-Colony Variants
title_full_unstemmed Adaption of an Episomal Antisense Silencing Approach for Investigation of the Phenotype Switch of Staphylococcus aureus Small-Colony Variants
title_short Adaption of an Episomal Antisense Silencing Approach for Investigation of the Phenotype Switch of Staphylococcus aureus Small-Colony Variants
title_sort adaption of an episomal antisense silencing approach for investigation of the phenotype switch of staphylococcus aureus small colony variants
topic Staphylococcus aureus
small-colony variant (SCV)
antisense silencing
phenotype switch
enoyl-acyl-carrier-protein reductase gene (fabI)
tet-regulatory expression system
url https://www.frontiersin.org/article/10.3389/fmicb.2019.02044/full
work_keys_str_mv AT ninaschleimer adaptionofanepisomalantisensesilencingapproachforinvestigationofthephenotypeswitchofstaphylococcusaureussmallcolonyvariants
AT ursulakaspar adaptionofanepisomalantisensesilencingapproachforinvestigationofthephenotypeswitchofstaphylococcusaureussmallcolonyvariants
AT brittaballhausen adaptionofanepisomalantisensesilencingapproachforinvestigationofthephenotypeswitchofstaphylococcusaureussmallcolonyvariants
AT sarahafotiadis adaptionofanepisomalantisensesilencingapproachforinvestigationofthephenotypeswitchofstaphylococcusaureussmallcolonyvariants
AT jessicamstreu adaptionofanepisomalantisensesilencingapproachforinvestigationofthephenotypeswitchofstaphylococcusaureussmallcolonyvariants
AT andrekriegeskorte adaptionofanepisomalantisensesilencingapproachforinvestigationofthephenotypeswitchofstaphylococcusaureussmallcolonyvariants
AT richardaproctor adaptionofanepisomalantisensesilencingapproachforinvestigationofthephenotypeswitchofstaphylococcusaureussmallcolonyvariants
AT karstenbecker adaptionofanepisomalantisensesilencingapproachforinvestigationofthephenotypeswitchofstaphylococcusaureussmallcolonyvariants